Industry Educational Session - A Four-Year Update: Clinical Data to Patient Outcomes in 3L+ DLBCL- Sponsored by Abbvie
Tracks
-
| Sunday, April 19, 2026 |
| 3:40 PM - 4:10 PM |
| Room 4, Upper Level |
Details
This AbbVie promotional symposium, “A Four Year Update: Clinical Data to Patient Outcomes in 3L+ DLBCL,” will reflect on updated evidence in 3L+ DLBCL and how it translates into patient outcomes. The programme will highlight longer-term data and explore practical considerations for identifying patients for treatment, including assessment of disease characteristics, performance status, comorbidities, and individual patient needs and preferences. Attendees will hear expert perspectives, review patient case examples, and have opportunity to participate in a live Q&A session.
This promotional symposium is organised and funded by AbbVie UK and is intended for UK healthcare professionals only.
AbbVie products will be discussed. Prescribing information and adverse event reporting information will be available at the symposium.
UK-EPCOR-260080, Feb 2026
Speaker
Dr. Wendy Osborne
Consultant Haematologist
Freeman Hospital Newcastle
Speaker One
Dr Wendy Osborne is Consultant Haematologist at Freeman hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust.
Prof. Andrew Davies
Professor Of Haematological Oncology
University of Southampton
Speaker Two
Prof Andrew Davies, BSc, BM, FRCP, PhD, is Professor of Haematological Oncology in the Cancer Sciences Unit in the Faculty of Medicine, University Hospital Southampton, Southampton, UK.
